聚焦品牌价值-最有价值和最强大的制药、医疗器械和医疗服务品牌的2026年度报告(英)-2026。China, accounting for 10%, continues to strengthen its global footprint as domestic players such as Sinopharm and Guangzhou Pharmaceutical increase investments in R&D, manufacturing capabilities, and international expansions.
聚焦品牌价值-最有价值和最强大的制药、医疗器械和医疗服务品牌的2026年度报告(英)-2026。China, accounting for 10%, continues to strengthen its global footprint as domestic players such as Sinopharm and Guangzhou Pharmaceutical increase investments in R&D, manufacturing capabilities, and international expansions.
聚焦品牌价值-最有价值和最强大的制药、医疗器械和医疗服务品牌的2026年度报告(英)-2026。China, accounting for 10%, continues to strengthen its global footprint as domestic players such as Sinopharm and Guangzhou Pharmaceutical increase investments in R&D, manufacturing capabilities, and international expansions.
覆盖 2026 年,全文共 45 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
适合行业研究员等读者参考。
重点分析了医疗器械、制药、品牌、品牌价值等议题。